Funding: Total expected funding is approximately $13.6M. Individual awards have cost caps of $2.0M for Research Level 1 and $3.2M for Research Level 2.
Doc Type: BAA
Clearance:No
Program Manager: help@eBRAP.org
Last Updated: 2026-08-19 14:44
Analyzed File:HT942526ORPCRA_GG.pdf
Eligibility Reasoning
Applications involving multidisciplinary collaborations among academia, industry, the DOW, the VA and other federal government agencies are highly encouraged... Funding obligated to intragovernmental and intramural DOW organizations will be sent through the Military Interdepartmental Purchase Request (MIPR), Funding Authorization Document (FAD) or Direct Charge Work Breakdown Structure processes.
Note: This is an AI-generated summary...
Summary
The Fiscal Year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) funds clinical research and trials on orthopaedic-specific factors and interventions to improve patient outcomes and inform clinical care for Service Members, Veterans, and the general public. Applications must address at least one of the specified FY26 focus areas. The award has two levels: Research Level 1 (RL1) supports clinical research projects with a total cost cap of $2.0M per award. Research Level 2 (RL2) supports clinical trials with a total cost cap of $3.2M per award. The maximum performance period for both is four years. RL1 focus areas are Ligamentous Trauma, Osseointegration Outcomes, Return-to-Duty Strategies, and Military Women’s Health. RL2 focus areas are Ligamentous Trauma, Limb Stabilization and Protection, and Return-to-Duty Strategies. Animal research is not permitted under this award.
Overall Technical Areas
Orthopaedic Clinical ResearchClinical Trial DesignLigamentous Trauma TreatmentMusculoskeletal Injury ResearchOsseointegration OutcomesPercutaneous Prosthetic LimbsReturn-to-Duty StrategiesOrthopaedic Military Women's HealthLimb Stabilization and ProtectionNovel Wound ProtectantsClinical Decision Support ToolsRehabilitation Strategy ValidationBiostatistics and Data AnalysisSex as a Biological Variable AnalysisRegulatory Strategy Development
Probable LBNL Areas
N/A
Focus Areas
Example Priorities:
Musculoskeletal extremity soft tissue trauma treatments for shoulder, knee or chronic ankle instability and sequelae only to optimize return to duty, work or reintegration.
Identification of best practices to optimize outcomes of patients who have percutaneous osseointegrated prosthetic limbs (e.g., infection, rejection, adapters and fail-safe devices, clinical outcomes).
Specific Technical Skills:
OsseointegrationProstheticsAmputee CareInfection ControlBiomaterialsImplant RejectionMedical Device DesignClinical Outcome AssessmentSurgical TechniquesRehabilitation Medicine
Potential PIs for this Area:
Name
Score
Organization
Example Priorities:
Optimization and/or validation of decision-support tools, interventions and/or rehabilitation strategies that can retain a Service Member on duty, enable them to return to duty within one year of injury, or avoid reinjury for common combat-related musculoskeletal injuries.
Capabilities for diagnosis of underlying pathology and efficacy of interventions measurements are encouraged.
Studies that assess the impact of novel or established orthopaedic injury care interventions on military women’s health.
Application must describe how outcomes of the proposed research will address areas and conditions that affect women uniquely, disproportionately or differently from men.
Areas of interest include preservation of function and physical ability, quality of life, symptom management and resilience in military women, as well as sex-specific considerations following orthopaedic injury and treatment.
Specific Technical Skills:
Women's HealthOrthopaedicsSex-specific MedicineClinical ResearchQuality of Life AssessmentSymptom ManagementHealth Disparities ResearchFunctional AssessmentMilitary MedicineResilience Research
Potential PIs for this Area:
Name
Score
Organization
Example Priorities:
Development and/or clinical evaluation of rapid limb stabilization and novel wound protectants for severely or critically wounded limbs to enable prolonged care and eventual transport to the point of definitive treatment.
In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.
ONHS Funding Opportunity Report